[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20053090D0 - Pulverformulering for innhalering inneholdende tiotropium. - Google Patents

Pulverformulering for innhalering inneholdende tiotropium.

Info

Publication number
NO20053090D0
NO20053090D0 NO20053090A NO20053090A NO20053090D0 NO 20053090 D0 NO20053090 D0 NO 20053090D0 NO 20053090 A NO20053090 A NO 20053090A NO 20053090 A NO20053090 A NO 20053090A NO 20053090 D0 NO20053090 D0 NO 20053090D0
Authority
NO
Norway
Prior art keywords
powder formulation
containing tiotropium
inhalation containing
inhalation
tiotropium
Prior art date
Application number
NO20053090A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053090L (no
Inventor
Michael Walz
Michael Trunk
Mareke Hartig-Heimel
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32308760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053090(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20053090L publication Critical patent/NO20053090L/no
Publication of NO20053090D0 publication Critical patent/NO20053090D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20053090A 2002-11-28 2005-06-23 Pulverformulering for innhalering inneholdende tiotropium. NO20053090D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255387A DE10255387A1 (de) 2002-11-28 2002-11-28 Neue Tiotropium-haltige Pulverformulierung für die Inhalation
PCT/EP2003/012911 WO2004047796A2 (fr) 2002-11-28 2003-11-19 Formulation pulverulente pour inhalation contenant du tiotropium

Publications (2)

Publication Number Publication Date
NO20053090L NO20053090L (no) 2005-06-23
NO20053090D0 true NO20053090D0 (no) 2005-06-23

Family

ID=32308760

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053090A NO20053090D0 (no) 2002-11-28 2005-06-23 Pulverformulering for innhalering inneholdende tiotropium.

Country Status (34)

Country Link
EP (1) EP1567135B1 (fr)
JP (1) JP4977321B2 (fr)
KR (1) KR101066805B1 (fr)
CN (1) CN100574751C (fr)
AR (1) AR042242A1 (fr)
AT (1) ATE401861T1 (fr)
AU (1) AU2003294714B2 (fr)
BR (1) BR0316343A (fr)
CA (1) CA2507579C (fr)
CO (1) CO5580736A2 (fr)
CY (1) CY1108420T1 (fr)
DE (2) DE10255387A1 (fr)
DK (1) DK1567135T3 (fr)
EA (1) EA011549B1 (fr)
EC (1) ECSP055821A (fr)
ES (1) ES2310681T3 (fr)
HK (1) HK1085918A1 (fr)
HR (1) HRP20050468A2 (fr)
IL (1) IL168810A (fr)
ME (1) MEP51608A (fr)
MX (1) MXPA05005485A (fr)
MY (1) MY140890A (fr)
NO (1) NO20053090D0 (fr)
PE (1) PE20040848A1 (fr)
PL (1) PL376229A1 (fr)
PT (1) PT1567135E (fr)
RS (1) RS20050400A (fr)
SA (1) SA04240467B1 (fr)
SI (1) SI1567135T1 (fr)
TW (1) TWI332837B (fr)
UA (1) UA81930C2 (fr)
UY (1) UY28096A1 (fr)
WO (1) WO2004047796A2 (fr)
ZA (1) ZA200502859B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006016904A1 (de) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator
DE102008014025A1 (de) * 2008-03-13 2009-09-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator und Sieb für einen Inhalator
TR200909788A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
EA024922B1 (ru) * 2010-08-03 2016-11-30 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Сухой порошковый препарат, содержащий ингибитор фосфодиэстеразы
WO2014074797A1 (fr) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Poudres pulmonaires de densité ultra basse
KR101748796B1 (ko) * 2015-09-30 2017-06-19 한미약품 주식회사 활성성분의 전달량이 향상된 흡입용 캡슐제
KR101728116B1 (ko) * 2015-11-03 2017-04-18 한미약품 주식회사 티오트로피움 또는 이의 약학적으로 허용가능한 염을 함유하는 흡입용 건조분말 조성물
CN111514418B (zh) * 2019-06-12 2022-01-14 中南大学湘雅二医院 一种自吸式经鼻粉末材料给送装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
DE4318455A1 (de) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
ATE382386T1 (de) * 1998-11-13 2008-01-15 Jagotec Ag Multidosis-trockenpulverinhalator mit pulverreservoir
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
ATE275391T1 (de) * 2000-10-12 2004-09-15 Boehringer Ingelheim Pharma Neue tiotropium-haltige inhalationspulver
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
CA2479919C (fr) * 2002-04-04 2011-05-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Preparations en poudre pour inhalation
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium

Also Published As

Publication number Publication date
HRP20050468A2 (en) 2006-07-31
ES2310681T3 (es) 2009-01-16
TWI332837B (en) 2010-11-11
MY140890A (en) 2010-01-29
CO5580736A2 (es) 2005-11-30
IL168810A (en) 2015-02-26
BR0316343A (pt) 2005-09-27
CA2507579A1 (fr) 2004-06-10
ZA200502859B (en) 2006-02-22
DE50310208D1 (de) 2008-09-04
KR101066805B1 (ko) 2011-09-22
CN1717225A (zh) 2006-01-04
CY1108420T1 (el) 2014-04-09
NO20053090L (no) 2005-06-23
HK1085918A1 (en) 2006-09-08
WO2004047796A2 (fr) 2004-06-10
AU2003294714A1 (en) 2004-06-18
EP1567135B1 (fr) 2008-07-23
KR20050086887A (ko) 2005-08-30
MXPA05005485A (es) 2005-07-25
EA011549B1 (ru) 2009-04-28
TW200500066A (en) 2005-01-01
UY28096A1 (es) 2004-06-30
MEP51608A (en) 2011-02-10
RS20050400A (en) 2007-04-10
DK1567135T3 (da) 2008-10-27
JP4977321B2 (ja) 2012-07-18
WO2004047796A3 (fr) 2004-09-30
PT1567135E (pt) 2008-09-01
CA2507579C (fr) 2011-07-19
AR042242A1 (es) 2005-06-15
UA81930C2 (uk) 2008-02-25
PL376229A1 (en) 2005-12-27
ECSP055821A (es) 2005-08-11
JP2006510622A (ja) 2006-03-30
AU2003294714B2 (en) 2009-10-08
PE20040848A1 (es) 2005-01-14
CN100574751C (zh) 2009-12-30
ATE401861T1 (de) 2008-08-15
EP1567135A2 (fr) 2005-08-31
SA04240467B1 (ar) 2008-10-15
EA200500864A1 (ru) 2006-02-24
DE10255387A1 (de) 2004-06-09
SI1567135T1 (sl) 2008-10-31

Similar Documents

Publication Publication Date Title
ATE326251T1 (de) Pulverinhalator
DK1670472T3 (da) Aerosolformulering til inhalation indeholdende et antikolinergikum
DK1615646T4 (da) Farmaceutiske formuleringer, der indeholder methylnaltrexon
EE200200428A (et) Uudne tiotroopiumi sisaldav inhalatsioonipulber
HK1080401A1 (en) Powder inhalation device
EP1635762A4 (fr) Poudres pharmaceutiques faiblement dosees inhalables
IL179757A0 (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
IL178689A0 (en) Pharmaceutical solution formulations containing 17-aag
HK1129111A1 (en) Tiotropium salts, pharmaceutical formulations containing the salts and the use thereof
HK1099753A1 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
IL169178A0 (en) Tiotropium containing hfc solution formulations
AU300689S (en) Powder inhalator
HK1085918A1 (en) Pulverulent formulation for inhalation containing tiotropium
AU2003294927A1 (en) Powder inhalator
DK1496876T3 (da) Aerosolformulering til inhalation indeholdende tiotropiumbromid
DE602004022810D1 (de) Mehrdosis-inhalator
NO20043489L (no) Sammensetning for inhalering
AP2006003734A0 (en) Inhalation formulation
DK1173244T3 (da) Pulverinhalator til kombineret medikament
ITMI20031342A1 (it) Dispositivo di inalazione di aerosol.
PL371356A1 (pl) Nowe związki, analogi sulforafanu i środek farmaceutyczny

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application